Literature DB >> 7983501

Phage F-116 transduction of antibiotic resistance from a clinical isolate of Pseudomonas aeruginosa.

J Blahová1, M Hupková, V Krcméry.   

Abstract

The lysate of phage F-116, propagated in a multiple drug resistant clinical isolate of Pseudomonas aeruginosa No. 131 was used to transduce determinants of antibiotic resistance to susceptible auxotrophic laboratory strains of the same species. The phage preparation, designated F-116/131 was found to transduce four determinants of resistance, i.e. to imipenem, cefotaxime, kanamycin and carbenicillin, but not to streptomycin, gentamicin, ceftazidime nor ciprofloxacin/ofloxacin. No conjugal transfer of any resistance determinants could be demonstrated in mating experiments using strain No. 131 and two rifampicin-resistant strains of P. aeruginosa which were highly susceptible to all antibiotics studied. These results might suggest that transduction could be an additional way to conjugational transfer of antibiotic resistance among P. aeruginosa.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7983501     DOI: 10.1080/1120009x.1994.11741150

Source DB:  PubMed          Journal:  J Chemother        ISSN: 1120-009X            Impact factor:   1.714


  3 in total

1.  Effect of antibiotic treatment on bacteriophage production by a cystic fibrosis epidemic strain of Pseudomonas aeruginosa.

Authors:  Joanne L Fothergill; Eilidh Mowat; Martin J Walshaw; Martin J Ledson; Chloe E James; Craig Winstanley
Journal:  Antimicrob Agents Chemother       Date:  2010-10-25       Impact factor: 5.191

2.  The effect of a bacteriophage on diversification of the opportunistic bacterial pathogen, Pseudomonas aeruginosa.

Authors:  Michael A Brockhurst; Angus Buckling; Paul B Rainey
Journal:  Proc Biol Sci       Date:  2005-07-07       Impact factor: 5.349

Review 3.  Epidemiology, Biology, and Impact of Clonal Pseudomonas aeruginosa Infections in Cystic Fibrosis.

Authors:  Michael D Parkins; Ranjani Somayaji; Valerie J Waters
Journal:  Clin Microbiol Rev       Date:  2018-08-29       Impact factor: 26.132

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.